| Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib D Marin, A Bazeos, FX Mahon, L Eliasson, D Milojkovic, M Bua, ... Journal of clinical oncology 28 (14), 2381-2388, 2010 | 1154 | 2010 |
| Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia S Picard, K Titier, G Etienne, E Teilhet, D Ducint, MA Bernard, R Lassalle, ... Blood 109 (8), 3496-3499, 2007 | 762 | 2007 |
| Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care M Molimard, C Raherison, S Lignot, F Depont, A Abouelfath, N Moore Journal of aerosol medicine 16 (3), 249-254, 2003 | 540 | 2003 |
| Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy AR Ibrahim, L Eliasson, JF Apperley, D Milojkovic, M Bua, R Szydlo, ... Blood, The Journal of the American Society of Hematology 117 (14), 3733-3736, 2011 | 407 | 2011 |
| The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD M Cazzola, M Molimard Pulmonary pharmacology & therapeutics 23 (4), 257-267, 2010 | 372 | 2010 |
| MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation J Bousquet, HJ Schunemann, J Fonseca, B Samolinski, C Bachert, ... Allergy 70 (11), 1372-1392, 2015 | 318 | 2015 |
| Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients M Molimard, C Raherison, S Lignot, A Balestra, S Lamarque, A Chartier, ... European Respiratory Journal 49 (2), 2017 | 317 | 2017 |
| Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study M Humbert, C Taillé, L Mala, V Le Gros, J Just, M Molimard, M Agossou, ... European Respiratory Journal 51 (5), 2018 | 297 | 2018 |
| Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia S Dulucq, S Bouchet, B Turcq, E Lippert, G Etienne, J Reiffers, ... Blood, The Journal of the American Society of Hematology 112 (5), 2024-2027, 2008 | 292 | 2008 |
| Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension C Guignabert, C Phan, A Seferian, A Huertas, LY Tu, R Thuillet, C Sattler, ... The Journal of clinical investigation 126 (9), 3207-3218, 2016 | 275 | 2016 |
| Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study N Lechevallier‐Michel, M Molimard, JF Dartigues, C Fabrigoule, ... British journal of clinical pharmacology 59 (2), 143-151, 2005 | 263 | 2005 |
| MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis J Bousquet, HJ Schünemann, PW Hellings, S Arnavielhe, C Bachert, ... Journal of Allergy and Clinical Immunology 138 (2), 367-374. e2, 2016 | 235 | 2016 |
| Integrated care pathways for airway diseases (AIRWAYS-ICPs) J Bousquet, A Addis, I Adcock, I Agache, A Agusti, A Alonso, ... European Respiratory Journal 44 (2), 304-323, 2014 | 226 | 2014 |
| Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans M Molimard, B Diquet, MS Benedetti Fundamental & clinical pharmacology 18 (4), 399-411, 2004 | 226 | 2004 |
| Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS S Bouchet, E Chauzit, D Ducint, N Castaing, M Canal-Raffin, N Moore, ... Clinica Chimica Acta 412 (11-12), 1060-1067, 2011 | 212 | 2011 |
| Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma AB Suttle, HA Ball, M Molimard, TE Hutson, C Carpenter, D Rajagopalan, ... British journal of cancer 111 (10), 1909-1916, 2014 | 207 | 2014 |
| Is diet partly responsible for differences in COVID‐19 death rates between and within countries? J Bousquet, JM Anto, G Iaccarino, W Czarlewski, T Haahtela, A Anto, ... Clinical and translational allergy 10 (1), 16, 2020 | 175 | 2020 |
| Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 J Bousquet, JM Anto, W Czarlewski, T Haahtela, SC Fonseca, G Iaccarino, ... Allergy 76 (3), 735-750, 2021 | 148 | 2021 |
| Effect of indacaterol, a novel long-acting β2-agonist, on isolated human bronchi E Naline, A Trifilieff, RA Fairhurst, C Advenier, M Molimard European Respiratory Journal 29 (3), 575-581, 2007 | 147 | 2007 |
| Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised … O Mir, C Cropet, M Toulmonde, A Le Cesne, M Molimard, E Bompas, ... The Lancet Oncology 17 (5), 632-641, 2016 | 140 | 2016 |
Bernard BégaudUniversité de BordeauxZweryfikowany adres z u-bordeaux.fr
